Nektar Therapeutics
NKTR • NASDAQ
Nektar Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Howard W. Robin, with a market cap of $2.2B.
Market Cap$2.2B
Employees137.0
CEOHoward W. Robin
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Nektar Therapeutics FAQ
Common questions about Nektar Therapeutics
Nektar Therapeutics is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $11.0M.
Nektar Therapeutics has approximately 137 employees.